AKT1 and colorectal carcinoma: In CRC, activation of the GPR109a-AKT axis by butyrate markedly reduces the membrane abundance of glucose transporter 1 (GLUT1) and glucose-6-phosphate dehydrogenase (G6PD), suppressing glucose uptake and glycolysis 108.